Global Vaccine Market

Global vaccine market by vaccine type (recombinant & conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines, others), by indication (diphtheria, pertussis, & tetanus (DTP), human papillomavirus (HPV), influenza, measles, mumps, & rubella (MMR), meningococcal disease, pneumococcal disease, rotavirus, others), by end user (pediatric, adults), by region (Asia Pacific, Europe, North America, Rest of the World (RoW)), outlook & forecast, 2021-2027

SKU: MGH01438 Category: Region:

USD3,000.00

Description

Vaccination is a simple, safe, and effective way of protecting people against harmful diseases before they come into contact with them. Garnering a CAGR of 6.7% from 2021 to 2027, the global vaccine market is projected to reach worth of USD 51,149 million by 2027-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vaccine market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the vaccine industry.

The vaccine market is segmented on the basis of vaccine type, indication, end user, and region. The vaccine market is segmented as below:

By vaccine type:
– recombinant & conjugate vaccines
– live attenuated vaccines
– inactivated vaccines
– toxoid vaccines
– others

By indication:
– diphtheria, pertussis, & tetanus (DTP)
– human papillomavirus (HPV)
– influenza
– measles, mumps, & rubella (MMR)
– meningococcal disease
– pneumococcal disease
– rotavirus
– others

By end user:
– pediatric
– adults

By region:
– region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report also provides a detailed analysis of several leading vaccine market vendors that include Abbott Laboratories, AstraZeneca plc, Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline plc, Johnson & Johnson (J&J), Merck & Co., Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global vaccine market.
– To classify and forecast the global vaccine market based on vaccine type, indication, end user, and region.
– To identify drivers and challenges for the global vaccine market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vaccine market.
– To identify and analyze the profile of leading players operating in the global vaccine market.

Why Choose This Report
– Gain a reliable outlook of the global vaccine market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Interested in this report? Get your FREE sample now!
Global Vaccine Market

Please fill out our form and we will get back to you.